OTCMKTS:SHIEF

Shield Therapeutics Stock Signals

etoro logo Buy SHIEF
*Your capital is at risk
$0.0793
+0 (+0%)
At Close: Jul 10, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Shield Therapeutics plc

General

Signal Type Signal Value Data
Score 0.000 113 days ( 43.36 %
Last Price $0.0793 0 %
Performance History
7 Days
$0.0800 $0.0793
-0.88%
30 Days
$0.0800 $0.0793
-0.88%
12 Mos
$0.0385 $0.0793
105.97%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 5.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0793 - $0.0793
Trend - 3 mos -51.54 % High Width: 129.54 %
Pred. range - 3 mos $0.0207 - $0.0474 Low -73.94 % - -40.17 %
Volume Direction Sell High Volume: 223 · Direction: 0
Pivot Short Buy Very Low Jul 09, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium May 11, 2026 - 42 days
Short/Long MA 3 mos Sell Medium May 14, 2026 - 39 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 48.82
Signal Type Signal Value Importance Data
Trend - 12 mos 46.79 % Very High Width: 122.68 %
Pred. range - 12 mos $0.117 - $0.260 High 47.21 % - 227.81 %
Short MA 12 mos Sell Very High May 11, 2026 - 42 days
Long MA 12 mos Sell Very High May 11, 2026 - 42 days
Short/Long MA 12 mos Sell Very High May 26, 2026 - 32 days
Pivot Long Buy Low Jul 09, 2026 - 2 days
RSI Long Pivot Signal Buy Low May 18, 2026 - 37 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SHIELD THERAPEUTICS PLC
Shield Therapeutics
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE